SARS-CoV-2 S1 Protein RBD (Beta B.1.351 Variant) from ABBEXA LTD

Search, find, compare suppliers for SARS-CoV-2 S1 Protein RBD (Beta B.1.351 Variant) products.

Edit 
Product NameSARS-CoV-2 S1 Protein RBD (Beta B.1.351 Variant)
DescriptionSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Spike S1 Protein Receptor-Binding Domain (RBD) is a recombinant protein expressed in Insect cells.

The SARS-CoV-2 Spike Protein (S protein) is a viral protein that allows the entry of SARS-CoV-2 into human cells. The protein forms trimers on the viral capsid and binds to human Angiotensin Converting Enzyme 2 (ACE2) located on the cell surface. The protein has a cleavage site between the S1 and S2 subunits that is targeted by the human enzyme Furin, and it may also cause the development of a syncytium (cell fusion). Antibodies to S protein can prevent viral entry as well as target the virus for further immune action.

The Beta (B.1.351) variant was first identified in South Africa. It contains the K417N, E484K and N501Y mutations in the spike protein?s receptor-binding domain. 319-541 AA. C-terminal His tag. Purity ≥ 90% (SDS-PAGE). Calculated MW: 26 kDa
Observed MW (12% reducing SDS-PAGE): ~28 kDa
Size1 mg
Concentration2.5 mg/ml
ApplicationsELISA, WB
Other NamesSevere Acute Respiratory Syndrome Coronavirus 2, SARS-CoV-2, COVID-19, 2019-nCoV, 2019 novel coronavirus, COVID19, SARS-CoV-2 Spike S1 (RBD), SARS-CoV-2 Spike S1 RBD (Receptor-Binding Domain) Protein, SARS-CoV-2 S1 Protein RBD (South Africa B.1.351 Variant), SARS-CoV-2 S1 Protein RBD (B.1.351 South Africa Variant), SARS-CoV-2 S1 Protein RBD (B.1.351 South African Variant), SARS-CoV-2 S1 Protein RBD (South Africa 501Y.V2 Variant), SARS-CoV-2 S1 Protein RBD (501Y.V2 South Africa Variant), SARS-CoV-2 S1 Protein RBD (501Y.V2 South African Variant), SARS-CoV-2 S1 Protein RBD K417N, E484K and N501Y Mutation, SARS-CoV-2 S1 Protein RBD (Beta B.1.351 Variant), SARS-CoV-2 S1 Protein RBD (Beta Variant), Severe Acute Respiratory Syndrome Coronavirus 2 protein, Protein Severe Acute Respiratory Syndrome Coronavirus 2, Virus Severe Acute Respiratory Syndrome Coronavirus 2 Protein, Virus Severe Acute Respiratory Syndrome Coronavirus 2, Virus protein Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV-2 protein, Protein SARS-CoV-2, Virus SARS-CoV-2 Protein, Virus SARS-CoV-2, Virus protein SARS-CoV-2, COVID-19 protein, Protein COVID-19, Virus COVID-19 Protein, Virus COVID-19, Virus protein COVID-19, 2019-nCoV protein, Protein 2019-nCoV, Virus 2019-nCoV Protein, Virus 2019-nCoV, Virus protein 2019-nCoV, 2019 novel coronavirus protein, Protein 2019 novel coronavirus, Virus 2019 novel coronavirus Protein, Virus 2019 novel coronavirus, Virus protein 2019 novel coronavirus, COVID19 protein, Protein COVID19, Virus COVID19 Protein, Virus COVID19, Virus protein COVID19, SARS-CoV-2 Spike S1 (RBD) protein, Protein SARS-CoV-2 Spike S1 (RBD), Virus SARS-CoV-2 Spike S1 (RBD) Protein, Virus SARS-CoV-2 Spike S1 (RBD), Virus protein SARS-CoV-2 Spike S1 (RBD), SARS-CoV-2 Spike S1 RBD (Receptor-Binding Domain) Protein protein, Protein SARS-CoV-2 Spike S1 RBD (Receptor-Binding Domain) Protein, Virus SARS-CoV-2 Spike S1 RBD (Receptor-Binding Domain) Protein Protein, Virus SARS-CoV-2 Spike S1 RBD (Receptor-Binding Domain) Protein, Virus protein SARS-CoV-2 Spike S1 RBD (Receptor-Binding Domain) Protein, SARS-CoV-2 S1 Protein RBD (South Africa B.1.351 Variant) protein, Protein SARS-CoV-2 S1 Protein RBD (South Africa B.1.351 Variant), Virus SARS-CoV-2 S1 Protein RBD (South Africa B.1.351 Variant) Protein, Virus SARS-CoV-2 S1 Protein RBD (South Africa B.1.351 Variant), Virus protein SARS-CoV-2 S1 Protein RBD (South Africa B.1.351 Variant), SARS-CoV-2 S1 Protein RBD (B.1.351 South Africa Variant) protein, Protein SARS-CoV-2 S1 Protein RBD (B.1.351 South Africa Variant), Virus SARS-CoV-2 S1 Protein RBD (B.1.351 South Africa Variant) Protein, Virus SARS-CoV-2 S1 Protein RBD (B.1.351 South Africa Variant), Virus protein SARS-CoV-2 S1 Protein RBD (B.1.351 South Africa Variant), SARS-CoV-2 S1 Protein RBD (B.1.351 South African Variant) protein, Protein SARS-CoV-2 S1 Protein RBD (B.1.351 South African Variant), Virus SARS-CoV-2 S1 Protein RBD (B.1.351 South African Variant) Protein, Virus SARS-CoV-2 S1 Protein RBD (B.1.351 South African Variant), Virus protein SARS-CoV-2 S1 Protein RBD (B.1.351 South African Variant), SARS-CoV-2 S1 Protein RBD (South Africa 501Y.V2 Variant) protein, Protein SARS-CoV-2 S1 Protein RBD (South Africa 501Y.V2 Variant), Virus SARS-CoV-2 S1 Protein RBD (South Africa 501Y.V2 Variant) Protein, Virus SARS-CoV-2 S1 Protein RBD (South Africa 501Y.V2 Variant), Virus protein SARS-CoV-2 S1 Protein RBD (South Africa 501Y.V2 Variant), SARS-CoV-2 S1 Protein RBD (501Y.V2 South Africa Variant) protein, Protein SARS-CoV-2 S1 Protein RBD (501Y.V2 South Africa Variant), Virus SARS-CoV-2 S1 Protein RBD (501Y.V2 South Africa Variant) Protein, Virus SARS-CoV-2 S1 Protein RBD (501Y.V2 South Africa Variant), Virus protein SARS-CoV-2 S1 Protein RBD (501Y.V2 South Africa Variant), SARS-CoV-2 S1 Protein RBD (501Y.V2 South African Variant) protein, Protein SARS-CoV-2 S1 Protein RBD (501Y.V2 South African Variant), Virus SARS-CoV-2 S1 Protein RBD (501Y.V2 South African Variant) Protein, Virus SARS-CoV-2 S1 Protein RBD (501Y.V2 South African Variant), Virus protein SARS-CoV-2 S1 Protein RBD (501Y.V2 South African Variant), SARS-CoV-2 S1 Protein RBD K417N, E484K and N501Y Mutation protein, Protein SARS-CoV-2 S1 Protein RBD K417N, E484K and N501Y Mutation, Virus SARS-CoV-2 S1 Protein RBD K417N, E484K and N501Y Mutation Protein, Virus SARS-CoV-2 S1 Protein RBD K417N, E484K and N501Y Mutation, Virus protein SARS-CoV-2 S1 Protein RBD K417N, E484K and N501Y Mutation, SARS-CoV-2 S1 Protein RBD (Beta B.1.351 Variant) protein, Protein SARS-CoV-2 S1 Protein RBD (Beta B.1.351 Variant), Virus SARS-CoV-2 S1 Protein RBD (Beta B.1.351 Variant) Protein, Virus SARS-CoV-2 S1 Protein RBD (Beta B.1.351 Variant), Virus protein SARS-CoV-2 S1 Protein RBD (Beta B.1.351 Variant), SARS-CoV-2 S1 Protein RBD (Beta Variant) protein, Protein SARS-CoV-2 S1 Protein RBD (Beta Variant), Virus SARS-CoV-2 S1 Protein RBD (Beta Variant) Protein, Virus SARS-CoV-2 S1 Protein RBD (Beta Variant), Virus protein SARS-CoV-2 S1 Protein RBD (Beta Variant)
Gene, Accession, CAS #n/a
Catalog #abx160085
Priceplease inquire
Order / More InfoSARS-CoV-2 S1 Protein RBD (Beta B.1.351 Variant) from ABBEXA LTD
Product Specific Referencesn/a
ABBEXA LTD
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950

Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com

https://www.abbexa.com

U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413

Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950


Profile of ABBEXA LTD
Return to Products

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.